Pharmaceuticals
MIRA Pharmaceuticals Secures Key Publication for Ketamir-2, a Next-Gen Ketamine Analog
Peer-reviewed journal spotlights differentiated pharmacology and therapeutic promise for neuropathic pain MIRA Pharmaceuticals (MIRA), a clinical-stage biotech firm focused on...
Telomir Pharmaceuticals Reports Breakthrough Anti-Aging Results in Preclinical Werner Syndrome Model
Lead candidate Telomir-1 reverses aging markers, restores muscle mass, and boosts survival in genetic progeria model Telomir Pharmaceuticals (TELO), a...
Telomir Pharmaceuticals Reports Breakthrough in Oral Therapy for Vision Loss
Telomir-1 reverses retinal degeneration and restores vision in advanced AMD zebrafish model Telomir Pharmaceuticals (TELO) announced a major preclinical breakthrough...
Telomir Pharmaceuticals Secures $3M Premium Equity Investment to Advance Rare Disease Program
Insider-Led Funding with No Warrants Strengthens Balance Sheet Ahead of IND Submission for Telomir-1 Telomir Pharmaceuticals (TELO), a biotech innovator...
Institutional Interest In Telomir Pharmaceuticals
Telomir Pharmaceuticals (TELO) has caught the attention of institutional investors, with JPMorgan Chase & Co. (JPM) significantly increasing its position...
Mira Pharmaceuticals Approves Acquisition of SKNY, Creating $60M+ Biotech Platform
Board approves merger following independent valuation; SKNY to contribute $5M in cash or assets at closing Mira Pharmaceuticals (MIRA), a...
Alpha Cognition Launches ZUNVEYL, First Oral Alzheimer’s Drug Approved by FDA in a Decade
32-Person Sales Team Targets $2 Billion Long-Term Care Market as Company Marks Major Milestone in Alzheimer’s Treatment Alpha Cognition (ACOG)...
FDA Closes Inspection of BioXcel’s TRANQUILITY II Trial Site, Reinforcing Data Integrity
BioXcel Therapeutics (BTAI) announced that the U.S. Food and Drug Administration (FDA) has officially closed its inspection of a single...
Hims & Hers Health Faces Crucial Earnings Test Amid Stock Volatility
Meme-Stock Frenzy Collides with Regulatory Uncertainty and Investor Skepticism Hims & Hers Health (HIMS) is at a crossroads as it...
Telomir Pharmaceuticals Achieves Breakthrough in Silver-Based Medical Science
Stabilizing Silver(II) for Enhanced Antimicrobial and Wound Healing Applications Telomir Pharmaceuticals (TELO) has announced a groundbreaking scientific achievement—its proprietary compound,...
